Goldman Sachs
HITK

Goldman Sachs’s HI-TECH PHARMACAL INC HITK Stock Holding History

Goldman Sachs’s Portfolio HITK Stock Details HITK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-110,708
Closed -$4.8M – 7333
2014
Q1 		$4.8M Buy
110,708
+49,869
+82% +$2.16M ﹤0.01% 3073
2013
Q4 		$2.64M Buy
60,839
+55,665
+1,076% +$2.41M ﹤0.01% 3783
2013
Q3 		$223K Sell
5,174
-4,211
-45% -$161K ﹤0.01% 5789
2013
Q2 		$312K Buy
+9,385
New +$312K ﹤0.01% 5307

Goldman Sachs's HITK Position: Q2 2014 in Review

Goldman Sachs sold out of HI-TECH PHARMACAL INC (HITK) in Q2 2014, closing a stake of 110,708 shares — an estimated $4.8M sold.

Goldman Sachs first reported a position in HITK in Q2 2013 and held it in 4 quarters. The position peaked at $4.8M in Q1 2014. 0 funds tracked by Wall St. Rank hold HITK as of Q2 2014.

  • Goldman Sachs reported no remaining HI-TECH PHARMACAL INC position as of Q2 2014 after selling out during the quarter.
  • Goldman Sachs sold 110,708 HI-TECH PHARMACAL INC shares in Q2 2014, an estimated $4.8M.
  • Goldman Sachs first reported a position in HI-TECH PHARMACAL INC in Q2 2013 and held it in 4 quarters.
  • Goldman Sachs's HI-TECH PHARMACAL INC position peaked at $4.8M in Q1 2014.
  • 0 funds tracked by Wall St. Rank held HI-TECH PHARMACAL INC as of Q2 2014.

Based on Goldman Sachs's 13F filing for Q2 2014, filed 14 Aug 2014.